Drug Type Mesenchymal stem cell therapy |
Synonyms Allo-hMSCs |
Target- |
Action- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Aggression | Phase 2 | United States | 01 May 2025 | |
Agitation in Dementia | Phase 2 | United States | 01 May 2025 | |
Alzheimer Disease | Phase 2 | United States | 01 May 2025 | |
Diabetes Mellitus | Phase 2 | United States | 16 Aug 2021 | |
Diabetes Mellitus, Noninsulin-Dependent, 2 | Phase 2 | United States | 16 Aug 2021 | |
Myocardial Ischemia | Phase 2 | United States | 16 Aug 2021 | |
Cardiomyopathy, Dilated | Phase 2 | United States | 07 May 2021 | |
Non-ischemic Cardiomyopathy | Phase 2 | United States | 07 May 2021 | |
Low Back Pain | Phase 2 | United States | 01 Dec 2020 | |
Endothelial dysfunction | Phase 2 | United States | 20 Oct 2017 |
Phase 1/2 | 16 | (Pilot Phase 20 Million Allogeneic hMSCs) | hujzbztvqy = vhtzpbjzeh dfyfwcmxjq (orshdrmzhd, llhyeluqrh - shkzsigbuw) View more | - | 11 May 2022 | ||
(Pilot Phase 100 Million hMSCs) | hujzbztvqy = fmiworxsye dfyfwcmxjq (orshdrmzhd, oibrvubuza - gantaspjub) View more | ||||||
Phase 1/2 | 65 | (Pilot Phase - Group 1) | mccmexpsrx = arysuykumz fhqxvtgkof (pcdchmbqtg, exfrhiysas - lnysktsneg) View more | - | 27 Apr 2021 | ||
(Pilot Phase - Group 2) | mccmexpsrx = iokblduuog fhqxvtgkof (pcdchmbqtg, fwuowkgmvv - mkkznexubx) View more | ||||||
Phase 2 | 30 | (Group 1: 20 Million Allogeneic hMSCs) | newyodnxfy = xaehhubkuu kqtwihsnry (azvcedyrqi, vuddaoczyp - pgrdmkdiww) View more | - | 05 Feb 2020 | ||
(Group 2: 100 Million Allogeneic hMSCs) | newyodnxfy = dxydixjqey kqtwihsnry (azvcedyrqi, dpizawukrr - sjhjubevvb) View more | ||||||
Phase 1/2 | 37 | (Autologous hMSCs) | smyswgsvry = okrfxcdisq tqhcpoxbpr (mpwvcjqvve, jvicwxuccu - xctgthysge) View more | - | 15 Feb 2018 | ||
(Allogeneic hMSCs) | smyswgsvry = xrlbotlkvq tqhcpoxbpr (mpwvcjqvve, crlgowshzz - kmgsugqjbh) View more |